Patent · US Active

Immunostimulatory compositions

US11904014B2 · kind B2 · utility

0Cited by
1References
26Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 4, 2020
Grant dateFeb 20, 2024
Priority date
Expiry dateJan 21, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/6093
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the use of melanin, complexed with an antigen, as a immunostimulatory composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.